Related Experiment Video

Updated: Sep 20, 2026

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery
08:38

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Published on: August 16, 2019

[Pathogenetic mechanisms of nonsymptomatic myocardium ischemia]

L V Bogun

    Likars'Ka Sprava
    |August 2, 2003
    PubMed

    Insights

    Silent myocardial ischemia in coronary patients is reviewed. Atherosclerosis, vasospasm, and hemostasis disorders contribute to this condition.

    Area of Science:

    • Cardiology
    • Internal Medicine
    • Vascular Biology

    Context:

    • Silent myocardial ischemia is a critical issue in patients with coronary artery disease.
    • Understanding the underlying mechanisms is crucial for effective patient management.
    • Existing literature provides insights into the multifactorial nature of this condition.

    Purpose:

    • To review and synthesize current medical literature on silent myocardial ischemia in coronary patients.
    • To elucidate the roles of coronary atherosclerosis, vasospasm, and hemostasis disorders in the development of silent myocardial ischemia.

    Summary:

    • Coronary atherosclerosis, characterized by plaque buildup, is a primary driver of reduced blood flow.
    • Coronary vasospasm, or sudden constriction of arteries, can precipitate ischemic events.
    • Disorders of hemostasis, including plasmatic factors, contribute to thrombus formation and ischemia.

    Impact:

    • Highlights the complex interplay of factors contributing to silent myocardial ischemia.
    • Provides a foundation for further research into diagnostic and therapeutic strategies.
    • Aims to improve clinical recognition and management of silent myocardial ischemia in at-risk populations.

    More Related Videos

    A Modified Simple Method for Induction of Myocardial Infarction in Mice04:29

    A Modified Simple Method for Induction of Myocardial Infarction in Mice

    Published on: December 3, 2021

    Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice09:05

    Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

    Published on: May 4, 2015

    Related Concept Videos

    Myocarditis I: Introduction01:21

    Myocarditis I: Introduction

    Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
    Myocarditis II: Clinical Features and Diagnostic Tests01:27

    Myocarditis II: Clinical Features and Diagnostic Tests

    Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Mitral Stenosis I: Introduction01:22

    Mitral Stenosis I: Introduction

    Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
    Pathophysiology of Cardiac Performance01:29

    Pathophysiology of Cardiac Performance

    Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...